Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 1
2009 1
2011 1
2013 1
2014 2
2016 1
2017 2
2018 3
2019 3
2020 1
2021 5
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
PIK3CA-mutations in breast cancer.
Reinhardt K, Stückrath K, Hartung C, Kaufhold S, Uleer C, Hanf V, Lantzsch T, Peschel S, John J, Pöhler M, Bauer M, Bürrig FK, Weigert E, Buchmann J, Kantelhardt EJ, Thomssen C, Vetter M. Reinhardt K, et al. Among authors: vetter m. Breast Cancer Res Treat. 2022 Dec;196(3):483-493. doi: 10.1007/s10549-022-06637-w. Epub 2022 Oct 24. Breast Cancer Res Treat. 2022. PMID: 36279023 Free PMC article.
GRB2 is a BECN1 interacting protein that regulates autophagy.
Montero-Vergara J, Plachetta K, Kinch L, Bernhardt S, Kashyap K, Levine B, Thukral L, Vetter M, Thomssen C, Wiemann S, Peña-Llopis S, Jendrossek V, Vega-Rubin-de-Celis S. Montero-Vergara J, et al. Among authors: vetter m. Cell Death Dis. 2024 Jan 5;15(1):14. doi: 10.1038/s41419-023-06387-7. Cell Death Dis. 2024. PMID: 38182563 Free PMC article.
Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa.
Bauer M, Vetter M, Stückrath K, Yohannes M, Desalegn Z, Yalew T, Bekuretsion Y, Kenea TW, Joffe M, van den Berg EJ, Nikulu JI, Bakarou K, Manraj SS, Ogunbiyi OJ, Ekanem IO, Igbinoba F, Diomande M, Adebamowo C, Dzamalala CP, Anele AA, Zietsman A, Galukande M, Foerster M, Dos-Santos-Silva I, Liu B, Santos P, Jemal A, Abebe T, Wickenhauser C, Seliger B, McCormack V, Kantelhardt EJ. Bauer M, et al. Among authors: vetter m. Cancer Immunol Res. 2023 Jun 2;11(6):720-731. doi: 10.1158/2326-6066.CIR-22-0795. Cancer Immunol Res. 2023. PMID: 37058582 Free PMC article.
Intrinsic subtypes in Ethiopian breast cancer patient.
Desalegn Z, Yohannes M, Porsch M, Stückrath K, Anberber E, Santos P, Bauer M, Addissie A, Bekuretsion Y, Assefa M, Worku Y, Taylor L, Abebe T, Kantelhardt EJ, Vetter M. Desalegn Z, et al. Among authors: vetter m. Breast Cancer Res Treat. 2022 Dec;196(3):495-504. doi: 10.1007/s10549-022-06769-z. Epub 2022 Oct 25. Breast Cancer Res Treat. 2022. PMID: 36282363 Free PMC article.
Comparison of six breast cancer classifiers using qPCR.
Berchtold E, Vetter M, Gündert M, Csaba G, Fathke C, Ulbrich SE, Thomssen C, Zimmer R, Kantelhardt EJ. Berchtold E, et al. Among authors: vetter m. Bioinformatics. 2019 Sep 15;35(18):3412-3420. doi: 10.1093/bioinformatics/btz103. Bioinformatics. 2019. PMID: 30759193
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping.
Hartung C, Porsch M, Stückrath K, Kaufhold S, Staege MS, Hanf V, Lantzsch T, Uleer C, Peschel S, John J, Pöhler M, Weigert E, Buchmann J, Bürrig KF, Schüler K, Bethmann D, Große I, Kantelhardt EJ, Thomssen C, Vetter M. Hartung C, et al. Among authors: vetter m. Breast Care (Basel). 2021 Dec;16(6):637-647. doi: 10.1159/000519255. Epub 2021 Oct 19. Breast Care (Basel). 2021. PMID: 35082572 Free PMC article.
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
Bley N, Schott A, Müller S, Misiak D, Lederer M, Fuchs T, Aßmann C, Glaß M, Ihling C, Sinz A, Pazaitis N, Wickenhauser C, Vetter M, Ungurs O, Strauss HG, Thomssen C, Hüttelmaier S. Bley N, et al. Among authors: vetter m. RNA Biol. 2021 Mar;18(3):391-403. doi: 10.1080/15476286.2020.1812894. Epub 2020 Sep 2. RNA Biol. 2021. PMID: 32876513 Free PMC article.
Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy.
Mitra D, Vega-Rubin-de-Celis S, Royla N, Bernhardt S, Wilhelm H, Tarade N, Poschet G, Buettner M, Binenbaum I, Borgoni S, Vetter M, Kantelhardt EJ, Thomssen C, Chatziioannou A, Hell R, Kempa S, Müller-Decker K, Wiemann S. Mitra D, et al. Among authors: vetter m. Int J Cancer. 2021 Apr 15;148(8):1993-2009. doi: 10.1002/ijc.33456. Epub 2021 Jan 9. Int J Cancer. 2021. PMID: 33368291 Free article.
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts.
Berdiel-Acer M, Maia A, Hristova Z, Borgoni S, Vetter M, Burmester S, Becki C, Michels B, Abnaof K, Binenbaum I, Bethmann D, Chatziioannou A, Hasmann M, Thomssen C, Espinet E, Wiemann S. Berdiel-Acer M, et al. Among authors: vetter m. Oncogene. 2021 Apr;40(15):2651-2666. doi: 10.1038/s41388-021-01719-3. Epub 2021 Mar 10. Oncogene. 2021. PMID: 33692466 Free PMC article.
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
Schüler K, Bethmann D, Kaufhold S, Hartung C, Stückrath K, Lantzsch T, Uleer C, Hanf V, Peschel S, John J, Pöhler M, Buchmann J, Bürrig KF, Weigert E, Thomssen C, Kantelhardt EJ, Vetter M. Schüler K, et al. Among authors: vetter m. Diagnostics (Basel). 2022 Oct 18;12(10):2527. doi: 10.3390/diagnostics12102527. Diagnostics (Basel). 2022. PMID: 36292215 Free PMC article.
31 results